// App-Quantinova.ai

3372 : Semaphorin 3A normalizes the tumor vasculature and impairs tumor progression in a Nrp-1-independent manner

Researchers

Presenter

  • Federica Maione

Principal Investigators

  • Cristina Basilico

  • Elisa Vigna

  • Mauro Giacca

  • Guido Serini

  • Enrico Giraudo

Medical Centers

  • ICGEB, Trieste, Italy

  • Candiolo Cancer Institute, IRCCS, and Department of Science and Drug Technology, University of Turin, Candiolo, Italy.

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved